Get started
Author

Jan Posthumus

Observed names: J Posthumus, J. Posthumus, Posthumus, Jan
ORCID: 0000-0003-3773-5708
Observed ORCID: 0000-0003-3773-5708
OpenAlex ID: A5045591964
Cost‐of‐illness of patients with chronic hand eczema in routine care: results from a multicentre study in Germany
2011 · M. Augustin, D. Kuessner, et al. · British Journal of Dermatology · 55
Cost-of-illness Analysis of Patients with Chronic Hand Eczema in Routine Care in Germany: Focus on the Impact of Occupational Disease
2013 · T Diepgen, S Purwins, et al. · Acta Dermato Venereologica · 40
PDF
Cost-effectiveness analysis of isavuconazole versus voriconazole for the treatment of patients with possible invasive aspergillosis in Sweden
2019 · Lefteris Floros, Daniel Kuessner, et al. · BMC Infectious Diseases · 26
PDF
The Cost of Treating Mucormycosis with Isavuconazole Compared with Standard Therapy in the UK
2017 · Emma Bagshaw, Daniel Kuessner, et al. · Future Microbiology · 22
Systematic review and network meta-analysis of clinical outcomes associated with isavuconazole versus relevant comparators for patients with invasive aspergillosis
2018 · Raoul Herbrecht, Daniel Kuessner, et al. · Current Medical Research and Opinion · 20
PDF
Economic Impact of Treating Invasive Mold Disease with Isavuconazole Compared with Liposomal Amphotericin B in the UK
2018 · Emma Bagshaw, David A Enoch, et al. · Future Microbiology · 16
PDF
Unfavorable Outcomes and Their Risk Factors in Hospitalized Patients with Staphylococcus aureus Bacteremia in the US: A Multicenter Retrospective Cohort Study, 2020–2022
2025 · Marya D. Zilberberg, Brian H. Nathanson, et al. · Antibiotics · 4
A Network Meta-Analysis Comparing the Efficacy And Safety of Ceftobiprole and Selected Comparators in the Treatment of Hospital-Acquired Pneumonia
2014 · N. Pooley, S. Chadda, et al. · Value in Health · 4
PDF
The Cost Of Treating Mucormycosis With Isavuconazole Compared With Liposomal Amphotericin B Followed By Posaconazole In The United Kingdom: Economic Evaluation Of The Phase Iii Vital Study And Fungiscope Matched Case-Control Analysis
2016 · D Kuessner, E Bagshaw, et al. · Value in Health · 3
PSS14 Burden of Disease in Patients With Severe Chronic Hand Eczema in Germany
2011 · T.L. Diepgen, S. Purwins, et al. · Value in Health · 3
Economic Evaluation of Ceftobiprole Compared to a Combination of Linezolid with Ceftazidime in the Management of Hospitalised Pneunomia in Scotland
2013 · F.W. van der Scheer, D. Kuessner, et al. · Value in Health · 1
PDF
Pss4 Cost-of-illness in Patients With Chronic Hand Eczema: Results From a Multi-centre Study in Germany
2010 · M Augustin, S Purwins, et al. · Value in Health · 1
PDF
Pss35 Cost Comparison of Patients With Chronic Hand Eczema Covered by Statutory Vs. Occupational Health Insurances in Germany
2010 · T Diepgen, M Augustin, et al. · Value in Health · 1
HPR237 Value of the France Early Access Pathways: Highlighting Benefits for Patients and Industry Sponsors of the Novel Therapeutic Fosmanogepix Addressing High Unmet Clinical Needs in Invasive Fungal Infections
2025 · Tracey Tingle, Marc Engelhardt, et al. · Value in Health
CO111 Costs and Complications of Hospitalization among Survivors of S. aureusbacteremia in the US: A Multicenter Retrospective Cohort Study, 2020-2022
2025 · Marya Zilberberg, Brian H. Nathanson, et al. · Value in Health
P-827. Epidemiology of Favorable vs. Unfavorable Outcomes in Hospitalized Patients with S. aureus Bacteremia in the US: A Multicenter Retrospective Cohort Study
2025 · Marya D Zilberberg, Brian H Nathanson, et al. · Open Forum Infectious Diseases
Rhinovirus Infections and Biomarkers of Airway Inflammation Evaluated in Children Treated for Wheezing Exacerbations in Costa Rica
2011 · J. Posthumus, M. Soto-Quiros, et al. · Journal of Allergy and Clinical Immunology
PDF
Works count: 22
Citation count: 196
H-index: 6
I10-index: 6
Year
Topic
Type